Company also presenting at 11th Annual Conference on Carbon Capture Utilization & Sequestration
QUEBEC CITY, April 24, 2012 /CNW/ - CO2 Solutions Inc. (TSX-V: CST), an innovator in the field of enzyme-enabled carbon capture technology, announced today that Glenn Kelly, the Company's President and Chief Executive Officer, has been selected to present at the Clean Tech Investor Conference at this year's World Congress on Industrial Biotechnology & Bioprocessing.
Mr. Kelly will discuss recent progress related to the Company's carbon capture technology program and its ability to reduce carbon pollution from coal-fired power plants and other significant industrial sources of CO2 emissions. The presentation will take place on Tuesday, May 1st at 11:30 am ET in Orlando, Florida.
At the same conference, on Wednesday, May 2nd, at 10:30 am ET, Jonathan Carley, Vice President, Business Development of CO2 Solutions will participate in a presentation on the optimum performance properties of enzymes in the context of CO2 capture.
The World Congress on Industrial Biotechnology and Bioprocessing is the world's largest industrial biotechnology event for business leaders, investors and policy makers in biofuels, biobased products, and renewable chemicals. Entering its ninth year, the event will be held April 29 to May 2 in Orlando, Florida and will bring together more than 1,000 attendees. More information can be found at www.bio.org/events/conferences/welcome-2012-bio-world-congress .
Webcasts for these two presentations will not be provided by the conference sponsors. However, copies of CO2 Solutions' presentations will be posted on CO2 Solutions' website following the presentation dates.
On May 2nd, 2012, Dr. Sylvie Fradette, CO2 Solutions Inc. Vice President, Research & Development and Nathalie Penders-van Elk, M.Sc. and PD. Eng., from CO2 Solutions collaboration partner, Procede Gas Treating, will be presenting a poster at the 11th Annual Conference on Carbon Capture Utilization & Sequestration in Pittsburgh, PA. The poster is entitled "The kinetics of absorption of carbon dioxide in aqueous amine and carbonate solutions and carbonic anhydrase". Further details on this presentation and the conference can be found at www.carbonsq.com.
About CO2 Solutions Inc.
CO2 Solutions is an innovator in the field of enzyme-enabled carbon capture and has been actively working to develop and commercialize the technology for power plants and other large stationary sources of carbon pollution. In the process, CO2 Solutions has built an extensive patent portfolio covering the use of carbonic anhydrase, or analogues thereof, for the efficient post‐combustion capture of carbon dioxide with low‐energy aqueous solvents. Further information about CO2 Solutions can be found at www.co2solutions.com.
CO2 Solutions Forward-looking Statements
Certain statements in this news release may be forward-looking. These statements relate to future events or CO2 Solutions' future economic performance and reflect the current assumptions and expectations of management. Certain unknown factors may affect the events, economic performance and results of operations described herein. CO2 Solutions undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information:
Investor Relations and Media Contact:
416-815-0700, ext. 225